| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |